rs121434285
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_002225.5(IVD):c.596G>T(p.Gly199Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G199G) has been classified as Benign.
Frequency
Consequence
NM_002225.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IVD | NM_002225.5 | c.596G>T | p.Gly199Val | missense_variant | Exon 6 of 12 | ENST00000487418.8 | NP_002216.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IVD | ENST00000487418.8 | c.596G>T | p.Gly199Val | missense_variant | Exon 6 of 12 | 1 | NM_002225.5 | ENSP00000418397.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251480Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135916
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461882Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727244
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74356
ClinVar
Submissions by phenotype
Isovaleryl-CoA dehydrogenase deficiency Pathogenic:3Uncertain:1
Variant summary: IVD c.596G>T (p.Gly199Val) results in a non-conservative amino acid change located in the Acyl-CoA oxidase/dehydrogenase, middle domain (IPR006091) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251480 control chromosomes. c.596G>T has been reported in the literature in individuals affected with Isovaleryl-CoA Dehydrogenase Deficiency (e.g., Vockley_1991, Mohsen_1998, Internal data). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in an absence of detectable enzymatic activity, potentially due to protein misfolding (e.g., Mohsen_1998). The following publications have been ascertained in the context of this evaluation (PMID: 9665741, 2063866). ClinVar contains an entry for this variant (Variation ID: 3563). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
- -
This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 202 of the IVD protein (p.Gly202Val). This variant is present in population databases (rs121434285, gnomAD 0.002%). This missense change has been observed in individuals with isovaleric acidemia (PMID: 9665741; Invitae). This variant is also known as c.596G>T (p.Gly170Val). ClinVar contains an entry for this variant (Variation ID: 3563). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects IVD function (PMID: 9665741). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:1
The G202V missense variant in the IVD gene has been reported previously in association with isovaleric acidemia (IVA), using alternate nomenclature (G170V) (Vockley et al., 1991). Functional studies in E. coli suggest G202V has little detectable protein activity compared to wild type (Mohsen et al., 1998). The G202V variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G202V substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, Glycine 202 is located in the FAD binding domain of the isovaleryl-CoA dehydrogenase protein (Vockley et al., 1991). In summary, we interpret G202V to be a pathogenic variant. -
Isovaleric acidemia, type I Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at